Drug Discovery Services Global Market Opportunities And Strategies To 2033

Drug Discovery Services Market 2024 – By Type (Finished Wood Products, Wood Processing, Manufactured Wood Materials), By Distribution Channel (Offline, Online), By Application (Residential, Commercial And Industrial), And By Region, Opportunities And Strategies – Global Forecast To 2032

Drug Discovery Services Global Market Opportunities And Strategies To 2033

Starting Price : $5000.00 | Pages : 325 | Published : October 2024 | | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN

Drug Discovery Services Market Definition

Drug discovery services refer to the range of activities and expertise provided by specialized companies to assist pharmaceutical and biotechnology firms in discovering new drugs. Drug discovery services are essential in the pharmaceutical industry, focusing on the early stages of drug development to identify and validate potential drug candidates.

The drug discovery services market consists of sales, by entities (organizations, sole traders and partnerships), of drug discovery services that encompass various scientific and technical services aimed at accelerating the discovery process, enhancing efficiency and reducing costs for drug developers.

Drug Discovery Services Market Size

The global drug discovery services market reached a value of nearly $16,266.12 million in 2023, having grown at a compound annual growth rate (CAGR) of 10.39% since 2018. The market is expected to grow from $16,266.12 million in 2023 to $29,850.59 million in 2028 at a rate of 12.91%. The market is then expected to grow at a CAGR of 13.70% from 2028 and reach $56,722.27 million in 2033.

Growth in the historic period resulted from increased investments in pharmaceutical research and development (R&D), increased focus on personalized medicine, growing focus on drug discovery trials, government initiatives to accelerate drug discovery research and expansion of biopharmaceutical sector. Factors that negatively affected growth in the historic period were complex and time-consuming regulatory approval processes and low access to healthcare services and poor access to drugs.

Going forward, increasing aging population worldwide, growing public awareness about health and wellness, rising healthcare expenditure globally, growing incidence of chronic diseases and expanding healthcare infrastructure will drive the growth. Factor that could hinder the growth of the drug discovery services market in the future include high cost of drug discovery and increasing competition among pharmaceutical companies.  

Drug Discovery Services Market Drivers

The key drivers of the drug discovery services market include:

Increasing Aging Population Worldwide

The increasing size of the aging population globally is expected to propel the growth of the drug discovery services market in the forecast period. The need for novel treatments increases as the population ages and chronic diseases such as cancer, Parkinson's disease and Alzheimer's become more common. Tailored therapies are evolving due to the need for individualized medicine. Government and regulatory agencies finance and offer incentives for healthcare related to aging. Technological developments in biotechnology quicken the process of finding new drugs, providing the elderly population with cutting-edge treatments. For instance, according to the United Nations Population Fund, a US-based agency aimed at improving reproductive and maternal health worldwide, the demographic of individuals aged 60 and above is expected to rise from 149 million in 2022 to 347 million by 2050. India's elderly population is forecast to double by 2050, surpassing the number of children in the country.  Additionally, according to the United Nations Department of Economic and Social Affairs, a US-based intergovernmental agency, the global population of individuals aged 65 years or older is expected to increase dramatically, more than doubling from 761 million in 2021 to 1.6 billion by 2050. In 2021, one out of every ten individuals worldwide were 65 or older. By 2050, projections indicate that this age group will comprise one out of every six people globally.  Therefore, the increasing aging populations will drive the growth of the drug discovery services market.

Drug Discovery Services Market Restraints

The key restraints on the drug discovery services market include:

High Cost of Drug Discovery

The high cost of drug discovery is expected to limit the growth of the drug discovery services market during the forecast period. The high cost of drug discovery, including advanced technologies, preclinical and clinical trials and regulatory compliance, imposes a financial burden on pharmaceutical companies. This challenge, especially for smaller firms and startups, limits their investment in and outsourcing of drug discovery services, potentially restricting overall market growth as companies focus on cost-efficiency and risk mitigation. For instance, in February 2024, according to an analysis of 47 medicines by Reuters, a US-based news agency, the median annual list price for a new drug rose to $300,000 in 2023, up from $222,000 the previous year.  Additionally, in February 2023, according to an analysis of the top 20 global biopharmaceutical companies by Deloitte Touché Tohmatsu Limited, a UK-based multinational professional services and business services consultancy, there was a 15% increase in average drug development costs, reaching approximately $2.3 billion, reflecting the growing financial burden associated with drug development. Two recent studies revealed insights into the soaring expenses of developing new drugs, which averaged over $2 billion per therapy.  Therefore, the high cost of drug discovery will restrain the growth of the drug discovery services market.

Drug Discovery Services Market Trends

Major trends shaping the drug discovery services market include:

Integration Of AI-Driven Tools For Faster And More Efficient Drug Discovery

Major companies in the drug discovery services market are advancing pharmaceutical research through AI (artificial intelligence)-driven tools. These tools utilize AI and machine learning to enhance drug development stages, enabling rapid and precise data analysis. This accelerates drug discovery by identifying potential candidates and understanding molecular interactions more effectively than traditional methods, resulting in faster and more efficient drug development. For example, in December 2023, Merck KGaA, a Germany-based science and technology company, launched its AIDDISON drug discovery software, the first of its kind to integrate the Synthia retrosynthesis software application programming interface (API). AIDDISON combines generative AI, machine learning and computer-aided drug design to accelerate drug development. Leveraging over two decades of pharmaceutical research and development (R&D) data, it identifies compounds with essential drug properties from a vast pool of possibilities, facilitating faster and more efficient drug discovery processes.  Additionally, in May 2023, Google Cloud Platform, a US-based suite of cloud computing services, launched two AI-driven life sciences solutions to aid drug discovery and precision medicine for biotech, pharmaceutical and public sector entities at the Bio-IT World Conference. The Target and Lead Identification Suite aids in amino acid function identification and protein structure prediction, while the Multiomics Suite expedites genomic data analysis for designing precise treatments.

Advanced Robotic And Automation Technologies For Revolutionizing Drug Discovery

Players in the drug discovery services market are leveraging advanced robotics and automation technologies to enhance efficiency and precision. These innovations streamline target identification, compound screening and lead optimization. High-throughput screening accelerates compound testing, while automated systems ensure accurate synthesis and purification. This integration reduces development time and costs, fostering the discovery of innovative therapeutics. For example, in January 2023, Insilico Medicine, a Hong Kong-based biotechnology company that provides drug discovery services, launched its 6th generation Intelligent Robotics Lab in Suzhou, China, to expedite its AI-driven drug discovery process. The lab employs advanced robotics and automation to streamline drug discovery stages, spanning from target identification to lead optimization. It features automated, high-throughput screening for rapid compound testing against drug targets and robotic systems for compound synthesis and purification, facilitating the creation of novel drug candidates.

Opportunities And Recommendations In The Drug Discovery Services Market

Opportunities – The top opportunities in the drug discovery services market segmented by type will arise in the chemistry services segment, which will gain $7,781.43 million of global annual sales by 2028. The top opportunities in the drug discovery services market segmented by drug type will arise in the small molecule drug segment, which will gain $9,579.26 million of global annual sales by 2028. The top opportunities in the drug discovery services market segmented by process will arise in the lead optimization segment, which will gain $4,559.80 million of global annual sales by 2028. The top opportunities in the drug discovery services market segmented by end user will arise in the pharmaceutical and biotechnology companies segment, which will gain $9,418.45 million of global annual sales by 2028. The drug discovery services market size will gain the most in the USA at $3,881.53 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the drug discovery services companies to Focus on Leveraging AI in Drug Discovery Services, focus on robotics and automation in drug discovery services, focus on computational technologies in drug discovery, focus on comprehensive drug discovery solutions, focus on biology services segment growth, focus on strategic partnerships in drug discovery, expand in emerging markets, provide competitively priced offerings, participate in trade shows and events, continue to use B2B promotions and focus on pharmaceutical and biotechnology companies segment.

Drug Discovery Services Market Segmentation

The drug discovery services market is segmented by type, by process, by drug type and by end user.

By Type –
The drug discovery services market is segmented by type into:
    • a) Chemistry Services
    • b) Biology Services
The chemistry services market was the largest segment of the drug discovery services market segmented by type, accounting for 62.1% or $10,105.32 million of the total in 2023. Going forward, the biology services segment is expected to be the fastest growing segment in the drug discovery services market segmented by type, at a CAGR of 14.19% during 2023-2028.

By Process –
The drug discovery services market is segmented by process into:
    • a) Target Selection
    • b) Target Validation
    • c) Hit-To-Lead Identification
    • d) Lead Optimization
    • e) Candidate Validation
    • f) Other Processes
The lead optimization market was the largest segment of the drug discovery services market segmented by process, accounting for 27.9% or $4,543.98 million of the total in 2023. Going forward, the lead optimization segment is expected to be the fastest growing segment in the drug discovery services market segmented by process, at a CAGR of 14.91% during 2023-2028.

By Drug Type –
The drug discovery services market is segmented by drug type into:
    • a) Biologics Drug
    • b) Small Molecule Drug
The small molecule drug market was the largest segment of the drug discovery services market segmented by drug type, accounting for 73.5% or $11,956.05 million of the total in 2023. Going forward, the biologics drug segment is expected to be the fastest growing segment in the drug discovery services market segmented by drug type, at a CAGR of 14.05% during 2023-2028.

By End User –
The drug discovery services market is segmented by end user into:
    • a) Pharmaceutical And Biotechnology Companies
    • b) Academic Institutes
    • c) Other End Users
The pharmaceutical and biotechnology companies market was the largest segment of the drug discovery services market segmented by end user, accounting for 66.1% or $10,759.08 million of the total in 2023. Going forward, the pharmaceutical and biotechnology companies segment is expected to be the fastest growing segment in the drug discovery services market segmented by end user, at a CAGR of 13.40% during 2023-2028.

By Geography - The drug discovery services market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      • • Canada
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      • • Italy
      • • Spain
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the drug discovery services market, accounting for 39.7% or $6,458.34 million of the total in 2023. It was followed by Western Europe, Asia-Pacific and then the other regions. Going forward, the fastest-growing regions in the drug discovery services market will be Asia-Pacific and Africa where growth will be at CAGRs of 16.42% and 15.45% respectively. These will be followed by Middle East and South America where the markets are expected to grow at CAGRs of 14.07% and 13.14% respectively.

Drug Discovery Services Market Competitive Landscape

Major Competitors are:

  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific Inc.
  • Laboratory Corporation of America Holdings
  • Evotec SE
  • Eurofins Scientific SE
  • Other Competitors Include:

  • Syngene International Limited
  • SRI International
  • Viva Biotech
  • Jubilant Biosys Ltd.
  • WuXi AppTec Co., Ltd.
  • Shionogi and Company Limited
  • Insilico Medicine
  • BioDuro-Sundia
  • X-Chem
  • Aurigene Pharmaceutical Services
  • Fujitsu Limited
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd
  • Hisun Pharmaceutical Co., Ltd.
  • Aragen Life Sciences Private Limited
  • Enzene Biosciences
  • Merck Group
  • Arctoris Ltd
  • Sygnature Discovery
  • Exscientia
  • Novartis AG
  • ChemAxon Ltd.
  • Selvita S.A
  • Ampersand Biomedicines Inc
  • Abcheck S.r.o
  • Gedeon Richter Plc
  • Nuritas, Ltd
  • Sage Bionetworks
  • ICON plc
  • Labcorp Drug Development
  • BioClinica
  • Q2 Solutions
  • Almac Group
  • Celerion
  • Bago Group
  • Aché Laboratórios Farmacêuticos
  • Laboratorio Eriochem
  • Laboratório Sanofi-Brasil
  • Laboratorio Farmacéutico GSK Chile
  • Prepaire Labs
  • AstraZeneca
  • Eli Lilly
  • AbbVie
  • GlaxoSmithKline
  • Novo Nordisk
  • Roche
  • Pharco Pharmaceuticals
  • EIPICO (Egyptian International Pharmaceutical Industries Co.)
  • Fidson Healthcare Plc
  • Aspen Pharmacare
  • Adcock Ingram
  • Ascendis Health
  • Seda Pharmaceuticals
  • Neimeth International Pharmaceuticals Plc
    1. Table Of Contents

      1 Executive Summary

      1.1 Drug Discovery Services – Market Attractiveness And Macro economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 Drug Discovery Services Market Definition And Segmentations

      6.4 Market Segmentation By Type

      6.4.1 Chemistry Services

      6.4.2 Biology Services

      6.5 Market Segmentation By Process

      6.5.1 Target Selection

      6.5.2 Target Validation

      6.5.3 Hit-To-Lead Identification

      6.5.4 Lead Optimization

      6.5.5 Candidate Validation

      6.5.6 Other Processes

      6.6 Market Segmentation By Drug Type

      6.6.1 Biologics Drug

      6.6.2 Small Molecule Drug

      6.7 Market Segmentation By End User

      6.7.1 Pharmaceutical And Biotechnology Companies

      6.7.2 Academic Institutes

      6.7.3 Other End Users

      7 Major Market Trends

      7.1 Integration Of AI-Driven Tools For Faster And More Efficient Drug Discovery

      7.2 Advanced Robotic And Automation Technologies For Revolutionizing Drug Discovery

      7.3 Transforming Drug Development With Cutting-Edge Computational Technologies

      7.4 Comprehensive Drug Discovery Solutions For Enhanced Biotech Industry Support

      7.5 Strategic Partnerships And Collaborations Among Major Players

      7.6 Launch Of Generative AI Microservices To Advance Drug Discovery, Medtech And Digital Health

      8 Drug Discovery Services Market - Macro Economic Scenario

      8.1 COVID-19 Impact On The Drug Discovery Services Market

      8.2 Impact Of The War In Ukraine On The Drug Discovery Services Market

      8.3 Impact Of High Inflation On The Drug Discovery Services Market

      9 Global Market Size And Growth

      9.1 Market Size

      9.2 Historic Market Growth, 2018 – 2023, Value ($ Million)

      9.2.1 Market Drivers 2018 – 2023

      9.2.2 Market Restraints 2018 – 2023

      9.3 Forecast Market Growth, 2023 – 2028, 2033F Value ($ Million)

      9.3.1 Market Drivers 2023 – 2028

      9.3.2 Market Restraints 2023 – 2028

      10 Global Drug Discovery Services Market Segmentation

      10.1 Global Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.2 Global Drug Discovery Services Market, Segmentation By Drug Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.3 Global Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      10.4 Global Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11 Drug Discovery Services Market, Regional and Country Analysis

      11.1 Global Drug Discovery Services Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      11.2 Global Drug Discovery Services Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12 Asia-Pacific Market

      12.1 Summary

      12.1.1 Market Overview

      12.1.2 Region Information

      12.1.3 Market Information

      12.1.4 Background Information

      12.1.5 Government Initiatives

      12.1.6 Regulations

      12.1.7 Regulatory Bodies

      12.1.8 Major Associations

      12.1.9 Taxes Levied

      12.1.10 Corporate Tax Structure

      12.1.11 Investments

      12.1.12 Major Companies

      12.2 Asia-Pacific Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.3 Asia-Pacific Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.4 Asia-Pacific Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.5 Asia-Pacific Drug Discovery Services Market: Country Analysis

      12.6 China Market

      12.7 Summary

      12.7.1 Market Overview

      12.7.2 Country Information

      12.7.3 Market Information

      12.7.4 Background Information

      12.7.5 Government Initiatives

      12.7.6 Regulations

      12.7.7 Regulatory Bodies

      12.7.8 Major Associations

      12.7.9 Taxes Levied

      12.7.10 Corporate Tax Structure

      12.7.11 Investments

      12.7.12 Major Companies

      12.8 China Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.9 China Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.10 China Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.11 India Market

      12.12 India Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.13 India Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.14 India Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.15 Japan Market

      12.16 Japan Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.17 Japan Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.18 Japan Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.19 Australia Market

      12.20 Australia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.21 Australia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.22 Australia Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.23 Indonesia Market

      12.24 Indonesia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.25 Indonesia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.26 Indonesia Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.27 South Korea Market

      12.28 South Korea Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.29 South Korea Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      12.30 South Korea Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13 Western Europe Market

      13.1 Summary

      13.1.1 Market Overview

      13.1.2 Region Information

      13.1.3 Market Information

      13.1.4 Background Information

      13.1.5 Government Initiatives

      13.1.6 Regulations

      13.1.7 Regulatory Bodies

      13.1.8 Major Associations

      13.1.9 Taxes Levied

      13.1.10 Corporate Tax Structure

      13.1.11 Investments

      13.1.12 Major Companies

      13.2 Western Europe Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.3 Western Europe Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.4 Western Europe Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.5 Western Europe Drug Discovery Services Market: Country Analysis

      13.6 UK Market

      13.7 UK Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.8 UK Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.9 UK Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.10 Germany Market

      13.11 Germany Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.12 Germany Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.13 Germany Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.14 France Market

      13.15 France Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.16 France Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.17 France Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.18 Italy Market

      13.19 Italy Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.20 Italy Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.21 Italy Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.22 Spain Market

      13.23 Spain Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.24 Spain Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      13.25 Spain Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14 Eastern Europe Market

      14.1 Summary

      14.1.1 Market Overview

      14.1.2 Region Information

      14.1.3 Market Information

      14.1.4 Background Information

      14.1.5 Government Initiatives

      14.1.6 Regulations

      14.1.7 Regulatory Bodies

      14.1.8 Major Associations

      14.1.9 Taxes Levied

      14.1.10 Corporate Tax Structure

      14.1.11 Investments

      14.1.12 Major Companies

      14.2 Eastern Europe Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.3 Eastern Europe Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.4 Eastern Europe Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.5 Eastern Europe Drug Discovery Services Market: Country Analysis

      14.6 Russia Market

      14.7 Russia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      14.8 Russia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15 North America Market

      15.1 Summary

      15.1.1 Market Overview

      15.1.2 199

      15.1.2 Region Information

      15.1.3 Market Information

      15.1.4 Background Information

      15.1.5 Government Initiatives

      15.1.6 Regulations

      15.1.7 Regulatory Bodies

      15.1.8 Major Associations

      15.1.9 Taxes Levied

      15.1.10 Corporate Tax Structure

      15.1.11 Investments

      15.1.12 Major Companies

      15.2 North America Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.3 North America Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.4 North America Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.5 North America Drug Discovery Services Market: Country Analysis

      15.6 USA Market

      15.7 Summary

      15.7.1 Market Overview

      15.7.2 212

      15.7.2 Country Information

      15.7.3 Market Information

      15.7.4 Background Information

      15.7.5 Government Initiatives

      15.7.6 Regulations

      15.7.3 Regulatory Bodies

      15.7.7 Major Associations

      15.7.8 Taxes Levied

      15.7.9 Corporate Tax Structure

      15.7.10 Investments

      15.7.11 Major Companies

      15.8 USA Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.9 USA Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.10 USA Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.11 Canada Market

      15.12 Canada Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.13 Canada Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      15.14 Canada Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16 South America Market

      16.1 Summary

      16.1.1 Market Overview

      16.1.2 231

      16.1.2 Region Information

      16.1.3 Market Information

      16.1.4 Background Information

      16.1.5 Government Initiatives

      16.1.6 Regulations

      16.1.7 Regulatory Bodies

      16.1.8 Major Associations

      16.1.9 Taxes Levied

      16.1.10 Corporate Tax Structure

      16.1.11 Investments

      16.1.12 Major Companies

      16.2 South America Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.3 South America Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.4 South America Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.5 South America Drug Discovery Services Market: Country Analysis

      16.6 Brazil Market

      16.7 Brazil Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.8 Brazil Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      16.9 Brazil Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17 Middle East Market

      17.1 Summary

      17.1.1 Market Overview

      17.1.2 Region Information

      17.1.3 Market Information

      17.1.4 Background Information

      17.1.5 Government Initiatives

      17.1.6 Regulations

      17.1.7 Regulatory Bodies

      17.1.8 Major Associations

      17.1.9 Taxes Levied

      17.1.10 Corporate Tax Structure

      17.1.11 Investments

      17.1.12 Major Companies

      17.2 Middle East Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.3 Middle East Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      17.4 Middle East Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18 Africa Market

      18.1 Summary

      18.1.1 Market Overview

      18.1.2 263

      18.1.3 263

      18.1.2 Region Information

      18.1.3 Market Information

      18.1.4 Background Information

      18.1.5 Government Initiatives

      18.1.6 Regulations

      18.1.7 Regulatory Bodies

      18.1.8 Major Associations

      18.1.9 Taxes Levied

      18.1.10 Corporate Tax Structure

      18.1.11 Investments

      18.1.12 Major Companies

      18.2 Africa Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.3 Africa Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      18.4 Africa Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, Value ($ Million)

      19 Competitive Landscape And Company Profiles

      19.1 Company Profiles

      19.2 Charles River Laboratories International, Inc

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.2.3 Business Strategy

      19.2.4 Financial Overview

      19.3 Thermo Fisher Scientific Inc

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.3.3 Business Strategy

      19.3.4 Financial Overview

      19.4 Laboratory Corporation of America Holdings (Labcorp)

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.4.3 Business Strategy

      19.4.4 Financial Overview

      19.5 Evotec SE

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.5.3 Business Strategy

      19.5.4 Financial Overview

      19.6 Eurofins Scientific SE

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.6.3 Business Strategy

      19.6.4 Financial Overview

      19.6 Selvita S.A.

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.6.3 Business Strategy

      19.6.4 Financial Overview

      19.7 Proteros Biostructures GmbH

      19.7.1 Company Overview

      19.7.2 Products And Services

      19.7.3 Business Strategy

      19.7.4 Financial Overview

      19.8 Axxam S.p.A

      19.8.1 Company Overview

      19.8.2 Products And Services

      19.8.3 Business Strategy

      19.8.4 Financial Overview

      19.9 Enamine Ltd

      19.9.1 Company Overview

      19.9.2 Products And Services

      19.9.3 Business Strategy

      19.9.4 Financial Overview

      20 Competitive Benchmarking

      21 Competitive Dashboard

      22 Key Mergers And Acquisitions

      22.1 Selvita Acquired PozLab

      22.2 Ampersand Biomedicines Acquired AbCheck

      22.3 Recursion Pharmaceuticals Acquired Cyclica And Valence

      22.4 Eurofins Discovery Acquired CALIXAR

      22.5 Sygnature Discovery Acquired SB Drug Discovery

      22.6 Charles River Laboratories International Acquired SAMDI Tech

      22.7 Verseon Acquired Edammo

      22.8 ZS Acquired Intomics A/S

      22.9 Bayer Acquired Vividion Therapeutics

      22.10 X-Chem Acquired IntelliSyn And AviSyn

      23 Opportunities And Strategies

      23.1 Global Drug Discovery Services Market In 2028 – Countries Offering Most New Opportunities

      23.2 Global Drug Discovery Services Market In 2028 – Segments Offering Most New Opportunities

      23.3 Global Drug Discovery Services Market In 2028 – Growth Strategies

      23.3.1 Market Trend Based Strategies

      23.3.2 Competitor Strategies

      24 Drug Discovery Services Market, Conclusions And Recommendations

      24.1 Conclusions

      24.2 Recommendations

      24.2.1 Product

      24.2.2 Place

      24.2.3 Price

      24.2.4 Promotion

      24.2.5 People

      25 Appendix

      25.1 Geographies Covered

      25.2 Market Data Sources

      25.3 Research Methodology

      25.4 Currencies

      25.5 The Business Research Company

      25.6 Copyright and Disclaimer

    List Of Tables

      Table 1: Global Drug Discovery Services Market, Historic, 2018 – 2023, $ Million
    • Table 2: Global Drug Discovery Services Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Table 3: Global Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 4: Global Drug Discovery Services Market, Segmentation By Drug Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 5: Global Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 6: Global Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 7: Global Drug Discovery Services Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 8: Global Drug Discovery Services Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 9: Asia-Pacific GDP Per Capita, By Country, 2018-2023, $
    • Table 10:  Asia-Pacific Population, By Country, 2018-2028, Millions
    • Table 11: Asia-Pacific Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 12: Asia-Pacific Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 13: Asia-Pacific Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 14: China GDP Per Capita, 2018-2023, $
    • Table 15:  China Population, 2018-2028, Millions
    • Table 16: China Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 17: China Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 18: China Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 19: India Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 20: India Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 21: India Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 22: Japan Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 23: Japan Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 24: Japan Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 25: Australia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 26: Australia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 27: Australia Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 28: Indonesia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 29: Indonesia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 30: Indonesia Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 31: South Korea Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 32: South Korea Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 33: South Korea Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 34: Western Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 35:  Western Europe Population, By Country, 2018-2028, Millions
    • Table 36: Western Europe Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 37: Western Europe Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 38: Western Europe Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 39: UK Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 40: UK Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 41: UK Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 42: Germany Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 43: Germany Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 44: Germany Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 45: France Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 46: France Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 47: France Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 48: Italy Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 49: Italy Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 50: Italy Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 51: Spain Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 52: Spain Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 53: Spain Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 54: Eastern Europe GDP Per Capita, By Country, 2018-2023, $
    • Table 55:  Eastern Europe Population, By Country, 2018-2028, Millions
    • Table 56: Eastern Europe Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 57: Eastern Europe Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 58: Eastern Europe Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 59: Russia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 60: Russia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 61: North America GDP Per Capita, By Country, 2018-2023, $
    • Table 62:  North America Population, By Country, 2018-2028, Millions
    • Table 63: North America Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 64: North America Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 65: North America Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 66: USA GDP Per Capita, 2018-2023, $
    • Table 67:  USA Population, 2018-2028, Millions
    • Table 68: USA Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 69: USA Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 70: USA Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 71: Canada Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 72: Canada Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 73: Canada Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 74: South America GDP Per Capita, By Country, 2018-2023, $
    • Table 75:  South America Population, By Country, 2018-2028, Millions
    • Table 76: South America Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 77: South America Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 78: South America Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 79: Brazil Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 80: Brazil Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 81: Brazil Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 82: Middle East GDP Per Capita, By Country, 2018-2023, $
    • Table 83:  Middle East Population, By Country, 2018-2028, Millions
    • Table 84: Middle East Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 85: Middle East Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 86: Middle East Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 87: Africa GDP Per Capita, By Country, 2018-2023, $
    • Table 88:  Africa Population, By Country, 2018-2028, Millions
    • Table 89: Africa Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 90: Africa Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 91: Africa Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Table 92: Global Drug Discovery Services Market, Key Competitor Estimated Market Shares, 2023, Percentage (%)
    • Table 93: Charles River Laboratories International, Inc – Financial Overview, 2019 – 2023, $ Billion
    • Table 94: Thermo Fisher Scientific Inc – Financial Overview, 2019 – 2023, $ Billion
    • Table 95: Laboratory Corporation of America Holdings – Financial Overview, 2019 – 2023, $ Billion
    • Table 96: Evotec SE – Financial Performance, 2019 – 2023, $ Billion
    • Table 97: Eurofins Scientific SE – Financial Overview, 2019 – 2023, $ Billion
    • Table 98: Drug Discovery Services Market, Competitive Benchmarking (In USD Billions)
    • Table 99: Drug Discovery Services Market, Competitive Dashboard
    • Table 100: Global Drug Discovery Services Market Size Gain ($ Million), 2023 – 2028, By Country
    • Table 101: Global Drug Discovery Services Market Size Gain ($ Million), Segmentation By Type, 2023 – 2028
    • Table 102: Global Drug Discovery Services Market Size Gain ($ Million), Segmentation By Drug Type, 2023 – 2028
    • Table 103: Global Drug Discovery Services Market Size Gain ($ Million), Segmentation By Process, 2023 – 2028
    • Table 104: Global Drug Discovery Services Market Size Gain ($ Million), Segmentation By End User, 2023 – 2028
    • Table 105: Drug Discovery Services Market Data Sources

    List Of Figures

      Figure 1: Global Drug Discovery Services Market Segmentation By Type
    • Figure 2: Global Drug Discovery Services Market Segmentation By Process
    • Figure 3: Global Drug Discovery Services Market Segmentation By Drug Type
    • Figure 4: Global Drug Discovery Services Market Segmentation By End User
    • Figure 5: Global Drug Discovery Services Market, Historic, 2018 – 2023, $ Million
    • Figure 6: Global Drug Discovery Services Market, Forecast, 2023 – 2028, 2033F, $ Million
    • Figure 7: Global Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 8: Global Drug Discovery Services Market, Segmentation By Drug Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 9: Global Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 10: Global Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 11: Global Drug Discovery Services Market, By Region, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 12: Global Drug Discovery Services Market, By Country, Historic and Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 13: Asia-Pacific Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 14: Asia-Pacific Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 15: Asia-Pacific Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 16: China Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 17: China Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 18: China Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 19: India Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 20: India Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 21: India Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 22: Japan Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 23: Japan Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 24: Japan Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 25: Australia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 26: Australia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 27: Australia Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 28: Indonesia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 29: Indonesia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 30: Indonesia Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 31: South Korea Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 32: South Korea Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 33: South Korea Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 34: Western Europe Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 35: Western Europe Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 36: Western Europe Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 37: UK Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 38: UK Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 39: UK Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 40: Germany Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 41: Germany Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 42: Germany Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 43: France Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 44: France Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 45: France Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 46: Italy Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 47: Italy Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 48: Italy Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 49: Spain Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 50: Spain Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 51: Spain Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 52: Eastern Europe Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 53: Eastern Europe Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 54: Eastern Europe Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 55: Russia Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 56: Russia Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 57: North America Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 58: North America Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 59: North America Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 60: USA Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 61: USA Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 62: USA Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 63: Canada Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 64: Canada Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 65: Canada Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 66: South America Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 67: South America Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 68: South America Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 69: Brazil Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 70: Brazil Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 71: Brazil Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 72: Middle East Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 73: Middle East Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 74: Middle East Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 75: Africa Drug Discovery Services Market, Segmentation By Type, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 76: Africa Drug Discovery Services Market, Segmentation By Process, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 77: Africa Drug Discovery Services Market, Segmentation By End User, Historic And Forecast, 2018 – 2023, 2028F, 2033F, $ Million
    • Figure 78: Global Drug Discovery Services, Key Competitor Estimated Market Shares, 2023, Percentage (%)
    • Figure 79: Charles River Laboratories International, Inc – Financial Overview, 2019 – 2023, $ Billion
    • Figure 80: Thermo Fisher Scientific Inc – Financial Overview, 2019 – 2023, $ Billion
    • Figure 81: Laboratory Corporation of America Holdings – Financial Overview, 2019 – 2023, $ Billion
    • Figure 82: Evotec SE – Financial Overview, 2019 – 2023, $ Billion
    • Figure 83: Eurofins Scientific SE – Financial Overview, 2019 – 2023, $ Billion
    • Figure 84: Geographic Regions Covered
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report
    View Report